Achira
Focus: Achira develops atomistic foundation simulation models to accelerate drug discovery, leveraging computational chemistry to predict molecular behavior. The company is early-stage and focused on neurology applications.
Profile data last refreshed 10h ago · AI intelligence enriched 2w ago
Total Funding
$33M
Open Jobs
7+2 this month
Stable — net +2 jobs in 30d
3 added, 1 removed. Backfill posture.
Should You Work at Achira?
AI assessmentAchira is a high-upside, high-risk bet for mission-driven technologists comfortable with pre-revenue uncertainty; not suitable for those seeking stability or established career ladders.
Why Work Here
- Join a computational drug discovery platform at the frontier of AI/ML in pharma with the potential to reshape how molecules are discovered
- Data science-heavy hiring (4 of 5 roles) indicates focus on building core technology moat rather than infrastructure
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Achira
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.